{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:21:19Z","timestamp":1792592479364,"version":"4.5.0"},"reference-count":185,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2023,12,25]],"date-time":"2023-12-25T00:00:00Z","timestamp":1703462400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life"],"abstract":"<jats:p>Nonalcoholic fatty liver disease (NAFLD) is one of the most common causes of chronic liver disease. As the second stage of developing steatosis, nonalcoholic hepatitis (NASH) carries the risk of fibrosis, cirrhosis, and hepatocellular carcinoma. Sarcopenia is defined as a condition characterized by a decrease in muscle mass and functional decline. Both NAFLD and sarcopenia are global problems. The pathophysiological mechanisms that link the two entities of the disease are insulin resistance, inflammation, nutritional deficiencies, impairment of myostatin and adiponectin, or physical inactivity. Furthermore, disorders of the gut-liver axis appear to induce the process of developing NAFLD and sarcopenia. The correlations between NAFLD and sarcopenia appear to be bidirectional, so the main objective of the review was to determine the cause-and-effect relationship between the two diseases.<\/jats:p>","DOI":"10.3390\/life14010037","type":"journal-article","created":{"date-parts":[[2023,12,25]],"date-time":"2023-12-25T23:00:12Z","timestamp":1703545212000},"page":"37","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["What Does Sarcopenia Have to Do with Nonalcoholic Fatty Liver Disease?"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5255-9648","authenticated-orcid":false,"given":"Katarzyna","family":"Ferenc","sequence":"first","affiliation":[{"name":"Institute of Medicine, Medical College of Rzeszow University, 35-959 Rzeszow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6896-4744","authenticated-orcid":false,"given":"Sara","family":"Jarmakiewicz-Czaja","sequence":"additional","affiliation":[{"name":"Institute of Health Sciences, Medical College of Rzeszow University, 35-959 Rzeszow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5954-151X","authenticated-orcid":false,"given":"Rafa\u0142","family":"Filip","sequence":"additional","affiliation":[{"name":"Institute of Medicine, Medical College of Rzeszow University, 35-959 Rzeszow, Poland"},{"name":"Department of Gastroenterology with IBD Unit, Clinical Hospital No. 2, 35-301 Rzeszow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,12,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Guo, X., Yin, X., Liu, Z., and Wang, J. (2022). Non-Alcoholic Fatty Liver Disease (NAFLD) Pathogenesis and Natural Products for Prevention and Treatment. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232415489"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/hep.25762","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association","volume":"55","author":"Chalasani","year":"2012","journal-title":"Hepatology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1038\/s41588-022-01199-5","article-title":"Multiomics study of nonalcoholic fatty liver disease","volume":"54","author":"Sveinbjornsson","year":"2022","journal-title":"Nat. Genet."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0016-5085(98)70599-2","article-title":"Steatohepatitis: A tale of two \u201chits\u201d?","volume":"114","author":"Day","year":"1998","journal-title":"Gastroenterology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1001\/jama.2015.5370","article-title":"Nonalcoholic fatty liver disease: A systematic review","volume":"313","author":"Rinella","year":"2015","journal-title":"JAMA"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_8","first-page":"1393","article-title":"Understanding the gut microbiota and sarcopenia: A systematic revie","volume":"12","author":"Liu","year":"2021","journal-title":"JCSM"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Noce, A., Marrone, G., Ottaviani, E., Guerriero, C., Di Daniele, F., Pietroboni Zaitseva, A., and Di Daniele, N. (2021). Uremic Sarcopenia and Its Possible Nutritional Approach. Nutrients, 13.","DOI":"10.3390\/nu13010147"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Kim, S.H., Jeong, J.B., Kang, J., Ahn, D.W., Kim, J.W., Kim, B.G., Lee, K.L., Oh, S., Yoon, S.H., and Park, S.J. (2021). Association between sarcopenia level and metabolic syndrome. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0248856"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jhep.2015.02.051","article-title":"Sarcopaenia is associated with NAFLD independently of obesity and insulin resistance: Nationwide surveys (KNHANES 2008\u20132011)","volume":"63","author":"Lee","year":"2015","journal-title":"J. Hepatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1097\/MEG.0000000000001397","article-title":"Associations between sarcopenia and nonalcoholic fatty liver disease and advanced fibrosis in the USA","volume":"31","author":"Wijarnpreecha","year":"2019","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1002\/hep.30049","article-title":"Relationship Between Relative Skeletal Muscle Mass and Nonalcoholic Fatty Liver Disease: A 7-Year Longitudinal Study","volume":"68","author":"Kim","year":"2018","journal-title":"Hepatology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1136\/gutjnl-2019-318813","article-title":"Epidemiology of chronic liver diseases in the USA in the past three decades","volume":"69","author":"Younossi","year":"2020","journal-title":"Gut"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Iwaki, M., Kobayashi, T., Nogami, A., Saito, S., Nakajima, A., and Yoneda, M. (2023). Impact of Sarcopenia on Non-Alcoholic Fatty Liver Disease. Nutrients, 15.","DOI":"10.3390\/nu15040891"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"119","DOI":"10.7861\/clinmedicine.7-2-119","article-title":"Hepatology outpatient service provision in secondary care: A study of liver disease incidence and resource costs","volume":"7","author":"Whalley","year":"2007","journal-title":"Clin. Med."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Nassir, F. (2022). NAFLD: Mechanisms, Treatments, and Biomarkers. Biomolecules, 12.","DOI":"10.3390\/biom12060824"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1053\/j.gastro.2014.11.039","article-title":"Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States","volume":"148","author":"Wong","year":"2015","journal-title":"Gastroenterology"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Pouwels, S., Sakran, N., Graham, Y., Leal, A., Pintar, T., Yang, W., Kassir, R., Singhal, R., Mahawar, K., and Ramnarain, D. (2022). Non-alcoholic fatty liver disease (NAFLD): A review of pathophysiology, clinical management and effects of weight loss. BMC Endocr. Disord., 22.","DOI":"10.1186\/s12902-022-00980-1"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"101134","DOI":"10.1016\/j.molmet.2020.101134","article-title":"Mitochondrial oxidative function in NAFLD: Friend or foe?","volume":"50","author":"Shum","year":"2021","journal-title":"Mol. Metab."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1038\/nm.3735","article-title":"Chronic enrichment of hepatic endoplasmic reticulum\u2013mitochondria contact leads to mitochondrial dysfunction in obesity","volume":"20","author":"Arruda","year":"2014","journal-title":"Nat. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/s42255-020-0209-6","article-title":"Resolution of NASH and hepatic fibrosis by the GLP-1R and GCGR dual-agonist cotadutide via modulating mitochondrial function and lipogenesis","volume":"2","author":"Boland","year":"2020","journal-title":"Nat. Metab."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1053\/j.gastro.2018.06.083","article-title":"Mitochondrial Dysfunction and Signaling in Chronic Liver Diseases","volume":"155","author":"Mansouri","year":"2018","journal-title":"Gastroenterology"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Paoli, A., and Cerullo, G. (2023). Investigating the Link between Ketogenic Diet, NAFLD, Mitochondria, and Oxidative Stress: A Narrative Review. Antioxidants, 12.","DOI":"10.3390\/antiox12051065"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Ilyas, Z., Perna, S., Alalwan, T.A., Zahid, M.N., Spadaccini, D., Gasparri, C., Peroni, G., Faragli, A., Alogna, A., and La Porta, E. (2022). The Ketogenic Diet: Is It an Answer for Sarcopenic Obesity?. Nutrients, 14.","DOI":"10.3390\/nu14030620"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1172\/JCI93465","article-title":"Familial NAFLD Cirrhosis Research Consortium. Nonalcoholic fatty liver disease with cirrhosis increases familial risk for advanced fibrosis","volume":"127","author":"Caussy","year":"2017","journal-title":"J. Clin. Investig."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1053\/j.gastro.2011.06.061","article-title":"Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States","volume":"141","author":"Charlton","year":"2011","journal-title":"Gastroenterology"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/hep.21327","article-title":"Long-term follow-up of patients with NAFLD and elevated liver enzymes","volume":"44","author":"Ekstedt","year":"2006","journal-title":"Hepatology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cld.2017.08.003","article-title":"The Natural History of Nonalcoholic Fatty Liver Disease-An Evolving View","volume":"22","author":"Lindenmeyer","year":"2018","journal-title":"Clin. Liver Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/nrgastro.2016.3","article-title":"Management of NAFLD: A stage-based approach","volume":"13","author":"Rinella","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/hep.29466","article-title":"Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease","volume":"67","author":"Estes","year":"2018","journal-title":"Hepatology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","article-title":"Non-alcoholic fatty liver disease\u2014A global public health perspective","volume":"70","author":"Younossi","year":"2019","journal-title":"J. Hepatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1055\/s-0038-1677517","article-title":"NASH in Lean Individuals","volume":"39","author":"Younes","year":"2019","journal-title":"Semin. Liver Dis."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/s41575-019-0169-z","article-title":"NAFLD in children: New genes, new diagnostic modalities and new drugs","volume":"16","author":"Nobili","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"International Consensus Panel. MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1136\/gutjnl-2017-313884","article-title":"Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases","volume":"66","author":"Adams","year":"2017","journal-title":"Gut"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jhep.2017.09.021","article-title":"Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?","volume":"68","author":"Lonardo","year":"2018","journal-title":"J. Hepatol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/gast.2001.25540","article-title":"Nonalcoholic fatty liver disease: Predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese","volume":"121","author":"Dixon","year":"2001","journal-title":"Gastroenterology"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1242\/dmm.001180","article-title":"A comprehensive definition for metabolic syndrome","volume":"2","author":"Huang","year":"2009","journal-title":"Dis. Model. Mech."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.3748\/wjg.v19.i22.3375","article-title":"What about non-alcoholic fatty liver disease as a new criterion to define metabolic syndrome?","volume":"19","author":"Tarantino","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1002\/hep.29546","article-title":"Nonalcoholic fatty liver disease incidence and impact on metabolic burden and death: A 20 year-community study","volume":"67","author":"Allen","year":"2018","journal-title":"Hepatology"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.metabol.2016.06.009","article-title":"Non-alcoholic fatty liver disease with and without metabolic syndrome: Different long-term outcomes","volume":"66","author":"Bloigu","year":"2017","journal-title":"Metabolism"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1016\/j.cgh.2019.12.026","article-title":"Nonalcoholic Fatty Liver Disease and Fibrosis Associated With Increased Risk of Cardiovascular Events in a Prospective Study","volume":"18","author":"Baratta","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e6712","DOI":"10.1097\/MD.0000000000006712","article-title":"Nonoverweight nonalcoholic fatty liver disease and incident cardiovascular disease: A post hoc analysis of a cohort study","volume":"96","author":"Yoshitaka","year":"2017","journal-title":"Medicine"},{"key":"ref_46","first-page":"833","article-title":"Non-alcoholic fatty liver disease and the incidence of myocardial infarction: A cohort study","volume":"35","author":"Kang","year":"2020","journal-title":"JGHF"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"33386","DOI":"10.1038\/srep33386","article-title":"Association of non-alcoholic fatty liver disease with major adverse cardiovascular events: A systematic review and meta-analysis","volume":"6","author":"Wu","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jhep.2016.05.013","article-title":"Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis","volume":"65","author":"Targher","year":"2016","journal-title":"J. Hepatol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/hep.27678","article-title":"Challenges and opportunities in drug and biomarker development for nonalcoholic steatohepatitis: Findings and recommendations from an American Association for the Study of Liver Diseases-U.S. Food and Drug Administration Joint Workshop","volume":"61","author":"Sanyal","year":"2015","journal-title":"Hepatology"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1080\/09637486.2016.1214239","article-title":"Mediterranean diet and nonalcoholic fatty liver disease: Molecular mechanisms of protection","volume":"68","author":"Godos","year":"2017","journal-title":"Int. J. Food Sci. Nutr."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Montemayor, S., Mascar\u00f3, C.M., Ugarriza, L., Casares, M., Llompart, I., Abete, I., Zulet, M.\u00c1., Mart\u00ednez, J.A., Tur, J.A., and Bouzas, C. (2022). Adherence to Mediterranean Diet and NAFLD in Patients with Metabolic Syndrome: The FLIPAN Study. Nutrients, 14.","DOI":"10.3390\/nu14153186"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Sch\u00fcbel, R., Nonnenmacher, T., Sookthai, D., Gonzalez Maldonado, S., Sowah, S.A., von Stackelberg, O., Schlett, C.L., Grafetst\u00e4tter, M., Nabers, D., and Johnson, T. (2019). Similar Weight Loss Induces Greater Improvements in Insulin Sensitivity and Liver Function among Individuals with NAFLD Compared to Individuals without NAFLD. Nutrients, 11.","DOI":"10.3390\/nu11030544"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/s41392-022-01119-3","article-title":"Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver\/steatohepatitis (NAFL\/NASH)","volume":"7","author":"Xu","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/cld.722","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases","volume":"11","author":"Chalasani","year":"2018","journal-title":"Clin. Liver Dis."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1111\/liv.15024","article-title":"Diet and exercise in NAFLD\/NASH: Beyond the obvious","volume":"41","author":"Semmler","year":"2021","journal-title":"Liver Int."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1172\/JCI94585","article-title":"Divergent effects of glucose and fructose on hepatic lipogenesis and insulin signaling","volume":"127","author":"Softic","year":"2017","journal-title":"J. Clin. Investig."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Eng, J.M., and Estall, J.L. (2021). Diet-Induced Models of Non-Alcoholic Fatty Liver Disease: Food for Thought on Sugar, Fat, and Cholesterol. Cells, 10.","DOI":"10.3390\/cells10071805"},{"key":"ref_58","first-page":"57","article-title":"Nutritional strategies for maintaining muscle mass and strength from middle age to later life: A narrative review","volume":"13","author":"Scott","year":"2020","journal-title":"Maturitas"},{"key":"ref_59","first-page":"16","article-title":"Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2. Sarcopenia: Revised European consensus on definition and diagnosis","volume":"48","author":"Bahat","year":"2019","journal-title":"Age Ageing"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.clnu.2009.12.004","article-title":"Consensus definition of sarcopenia, cachexia and pre-cachexia: Joint document elaborated by Special Interest Groups (SIG) \u201ccachexia-anorexia in chronic wasting diseases\u201d and \u201cnutrition in geriatrics\u201d","volume":"29","author":"Muscaritoli","year":"2010","journal-title":"Clin. Nutr."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.jjcc.2021.10.013","article-title":"Sarcopenia as a comorbidity of cardiovascular disease","volume":"79","author":"Sasaki","year":"2022","journal-title":"J. Cardiol."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Papadopoulou, S.K. (2020). Sarcopenia: A Contemporary Health Problem among Older Adult Populations. Nutrients, 12.","DOI":"10.3390\/nu12051293"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.bone.2017.09.008","article-title":"A review of sarcopenia: Enhancing awareness of an increasingly prevalent disease","volume":"105","author":"Marty","year":"2017","journal-title":"Bone"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.archger.2016.04.016","article-title":"Sarcopenia and its associated factors in Iranian older individuals: Results of SARIR study","volume":"66","author":"Hashemi","year":"2016","journal-title":"Arch. Gerontol. Geriatr."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S2213-8587(14)70034-8","article-title":"Age-related and disease-related muscle loss: The effect of diabetes, obesity, and other diseases","volume":"2","author":"Kalyani","year":"2014","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s12020-015-0577-y","article-title":"Optimal cutoffs for low skeletal muscle mass related to cardiovascular risk in adults: The Korea National Health and Nutrition Examination Survey 2009\u20132010","volume":"50","author":"Kim","year":"2015","journal-title":"Endocrine"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Kamimura, H., Sato, T., Natsui, K., Kobayashi, T., Yoshida, T., Kamimura, K., Tsuchiya, A., Murayama, T., Yokoyama, J., and Kawai, H. (2021). Molecular Mechanisms and Treatment of Sarcopenia in Liver Disease: A Review of Current Knowledge. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22031425"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1093\/ageing\/afu115","article-title":"Prevalence of and interventions for sarcopenia in ageing adults: A systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS)","volume":"43","author":"Landi","year":"2014","journal-title":"Age Ageing"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.maturitas.2015.08.006","article-title":"Prevalence and risk factors of sarcopenia among adults living in nursing homes","volume":"82","author":"Senior","year":"2015","journal-title":"Maturitas"},{"key":"ref_70","first-page":"412","article-title":"European Working Group on Sarcopenia in Older People. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People","volume":"39","author":"Baeyens","year":"2010","journal-title":"Age Ageing"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"882","DOI":"10.52586\/4995","article-title":"Sarcopenia and perioperative management of elderly surgical patients","volume":"26","author":"Shi","year":"2021","journal-title":"Front. Biosci."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cger.2016.08.002","article-title":"Pathogenesis and Management of Sarcopenia","volume":"33","author":"Dhillon","year":"2017","journal-title":"Clin. Geriatr. Med."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.3389\/fphys.2017.01045","article-title":"The Role of Inflammation in Age-Related Sarcopenia","volume":"12","author":"Dalle","year":"2017","journal-title":"Front. Physiol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1152\/physiol.00039.2014","article-title":"Mitochondria, muscle health, and exercise with advancing age","volume":"30","author":"Carter","year":"2015","journal-title":"Physiology"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/jcsm.12232","article-title":"Mitochondrial degeneration precedes the development of muscle atrophy in progression of cancer cachexia in tumour-bearing mice","volume":"8","author":"Brown","year":"2017","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"757","DOI":"10.2147\/CIA.S158513","article-title":"Oxidative stress, aging, and diseases","volume":"26","author":"Liguori","year":"2018","journal-title":"Clin. Interv. Aging"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1249\/JES.0000000000000101","article-title":"Mitochondria Initiate and Regulate Sarcopenia","volume":"45","author":"Alway","year":"2017","journal-title":"Exerc. Sport. Sci. Rev."},{"key":"ref_78","first-page":"422","article-title":"Mitochondrial Quality Control and Muscle Mass Maintenance","volume":"12","author":"Romanello","year":"2016","journal-title":"Front. Physiol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1172\/JCI64098","article-title":"Cellular senescence and the senescent secretory phenotype: Therapeutic opportunities","volume":"123","author":"Tchkonia","year":"2013","journal-title":"J. Clin. Investig."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1159\/000356760","article-title":"Sarcopenia, cachexia and aging: Diagnosis, mechanisms and therapeutic options\u2014A mini-review","volume":"60","author":"Ali","year":"2014","journal-title":"Gerontology."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.arr.2015.05.001","article-title":"Sarcopenia--The search for emerging biomarkers","volume":"22","author":"Kalinkovich","year":"2015","journal-title":"Ageing Res. Rev."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1007\/s12603-018-1079-4","article-title":"Respiratory Muscle Strength as a Discriminator of Sarcopenia in Community-Dwelling Elderly: A Cross-Sectional Study","volume":"22","author":"Ohara","year":"2018","journal-title":"J. Nutr. Health Aging"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s12603-021-1599-1","article-title":"Effects of Exercise Alone or in Combination with High-Protein Diet on Muscle Function, Aerobic Capacity, and Physical Function in Middle-Aged Obese Adults: A Randomized Controlled Trial","volume":"25","author":"Hsu","year":"2021","journal-title":"J. Nutr. Health Aging"},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Seo, M.-W., Jung, S.-W., Kim, S.-W., Lee, J.-M., Jung, H.C., and Song, J.-K. (2021). Effects of 16 Weeks of Resistance Training on Muscle Quality and Muscle Growth Factors in Older Adult Women with Sarcopenia: A Randomized Controlled Trial. Int. J. Environ. Res. Public Health, 18.","DOI":"10.3390\/ijerph18136762"},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Chiang, F.-Y., Chen, J.-R., Lee, W.-J., and Yang, S.-C. (2021). Effects of Milk or Soy Milk Combined with Mild Resistance Exercise on the Muscle Mass and Muscle Strength in Very Old Nursing Home Residents with Sarcopenia. Foods, 10.","DOI":"10.3390\/foods10112581"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"111644","DOI":"10.1016\/j.exger.2021.111644","article-title":"Sarcojoint\u00ae, the branched-chain amino acid-based supplement, plus resistance exercise improved muscle mass in adults aged 50 years and older: A double-blinded randomized controlled trial","volume":"157","author":"Peng","year":"2022","journal-title":"Exp. Gerontol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/ggi.13547","article-title":"Effects of branched-chain amino acids and vitamin D supplementation on physical function, muscle mass and strength, and nutritional status in sarcopenic older adults undergoing hospital-based rehabilitation: A multicenter randomized controlled trial","volume":"19","author":"Takeuchi","year":"2019","journal-title":"Geriatr. Gerontol. Int."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00423-023-03170-2","article-title":"Clinical impact of sarcopenia in early-stage intrahepatic recurrent hepatocellular carcinoma: An association with impaired host immunity","volume":"408","author":"Doi","year":"2023","journal-title":"Langenbecks Arch. Surg."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/cld.691","article-title":"Arresting Frailty and Sarcopenia in Cirrhosis:Future Prospects","volume":"11","author":"Chen","year":"2018","journal-title":"Clin. Liver Dis."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1016\/j.cgh.2017.04.004","article-title":"The Long Winding Road to Transplant: How Sarcopenia and Debility Impact Morbidity and Mortality on the Waitlist","volume":"15","author":"Bhanji","year":"2017","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jceh.2020.09.003","article-title":"Nutrition in Chronic Liver Disease: Consensus Statement of the Indian National Association for Study of the Liver","volume":"11","author":"Puri","year":"2021","journal-title":"J. Clin. Exp. Hepatol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"971913","DOI":"10.3389\/fnut.2022.971913","article-title":"Assessing causal relationships between sarcopenia and nonalcoholic fatty liver disease: A bidirectional Mendelian randomization study","volume":"9","author":"Zhao","year":"2022","journal-title":"Front. Nutr."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/cld.900","article-title":"Association of sarcopenia and NAFLD: An overview","volume":"16","author":"Li","year":"2020","journal-title":"Clin. Liver Dis."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/apt.13889","article-title":"Sarcopenia is associated with severe liver fibrosis in patients with non-alcoholic fatty liver disease","volume":"45","author":"Petta","year":"2017","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/hep.28376","article-title":"Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: Nationwide surveys (KNHANES 2008-2011)","volume":"63","author":"Lee","year":"2016","journal-title":"Hepatology"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jhep.2016.08.019","article-title":"Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis","volume":"66","author":"Koo","year":"2017","journal-title":"J. Hepatol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.jhep.2021.11.006","article-title":"Effect of sarcopenia on survival in patients with cirrhosis: A meta-analysis","volume":"76","author":"Tantai","year":"2022","journal-title":"J. Hepatol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.3748\/wjg.v24.i30.3330","article-title":"Nutritional issues in patients with obesity and cirrhosis","volume":"24","author":"Schiavo","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"147-S162","DOI":"10.1016\/j.jhep.2021.01.025","article-title":"Sarcopenia and frailty in decompensated cirrhosis","volume":"75","author":"Tandon","year":"2021","journal-title":"J. Hepatol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"R67","DOI":"10.1530\/JOE-15-0533","article-title":"Insulin resistance and sarcopenia: Mechanistic links beetween common co-morbidities","volume":"229","author":"Cleasby","year":"2016","journal-title":"J. Endocrinol."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Saeki, C., and Tsubota, A. (2021). Influencing Factors and Molecular Pathogenesis of Sarcopenia and Osteosarcopenia in Chronic Liver Disease. Life, 11.","DOI":"10.3390\/life11090899"},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Saeki, C., Kanai, T., Nakano, M., Oikawa, T., Torisu, Y., Abo, M., Saruta, M., and Tsubota, A. (2020). Relationship between Osteosarcopenia and Frailty in Patients with Chronic Liver Disease. J. Clin. Med., 9.","DOI":"10.3390\/jcm9082381"},{"key":"ref_103","first-page":"89","article-title":"Indices calculated by serum creatinine and cystatin C as predictors of liver damage, muscle strength and sarcopenia in liver disease","volume":"12","author":"Ichikawa","year":"2020","journal-title":"Biomed. Rep."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Yang, Y.J., and Kim, D.J. (2021). An Overview of the Molecular Mechanisms Contributing to Musculoskeletal Disorders in Chronic Liver Disease: Osteoporosis, Sarcopenia, and Osteoporotic Sarcopenia. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22052604"},{"key":"ref_105","first-page":"1213","article-title":"Sarcopenia in Chronic Liver Disease: A Metabolic Perspective","volume":"28","author":"Kumar","year":"2022","journal-title":"J. Clin. Transl. Hepatol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3748\/wjg.v18.i3.237","article-title":"Aging is a risk factor of nonalcoholic fatty liver disease in premenopausal women","volume":"18","author":"Hamaguchi","year":"2012","journal-title":"World J. Gastroenterol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1002\/hep.26716","article-title":"Relationship between sarcopenia and nonalcoholic fatty liver disease: The Korean Sarcopenic Obesity Study","volume":"59","author":"Hong","year":"2014","journal-title":"Hepatology"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1007\/s10620-016-4285-0","article-title":"Diet-Induced Nonalcoholic Fatty Liver Disease Is Associated with Sarcopenia and Decreased Serum Insulin-Like Growth Factor-1","volume":"61","author":"Cabrera","year":"2016","journal-title":"Dig. Dis. Sci."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3350\/cmh.2021.0082","article-title":"Association between serum tumor necrosis factor-\u03b1 and sarcopenia in liver cirrhosis","volume":"28","author":"Han","year":"2022","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jhep.2015.05.014","article-title":"Sarcopenia in non-alcoholic fatty liver disease: Targeting the real culprit?","volume":"63","author":"Merli","year":"2015","journal-title":"J. Hepatol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1096\/fj.05-4607fje","article-title":"Insulin resistance of muscle protein metabolism in aging","volume":"20","author":"Rasmussen","year":"2006","journal-title":"FASEB J."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1507\/endocrj.EJ12-0228","article-title":"Fatty liver as a consequence and cause of insulin resistance: Lessons from type 2 diabetic liver","volume":"59","author":"Takamura","year":"2012","journal-title":"Endocr. J."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"5S20","DOI":"10.1016\/S1262-3636(05)73648-X","article-title":"Insulin resistance: A contributing factor to age-related muscle mass loss?La r\u00e9sistance \u00e0 l\u2019insuline: Un facteur contribuant \u00e0 la fonte prot\u00e9ique musculaire li\u00e9e \u00e0 l\u2019\u00e2ge?","volume":"31","author":"Guillet","year":"2005","journal-title":"Diabetes Metab."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13098-023-01022-z","article-title":"Causal relationship between insulin resistance and sarcopenia","volume":"15","author":"Liu","year":"2023","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.3350\/cmh.2022.0358","article-title":"Interaction between sarcopenia and nonalcoholic fatty liver disease","volume":"29","author":"Joo","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Srikanthan, P., Hevener, A.L., and Karlamangla, A.S. (2010). Sarcopenia exacerbates obesity-associated insulin resistance and dysglycemia: Findings from the National Health and Nutrition Examination Survey III. PLoS ONE, 26.","DOI":"10.1371\/journal.pone.0010805"},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Zhai, Y., and Xiao, Q. (2017). The Common Mechanisms of Sarcopenia and NAFLD. Biomed. Res. Int., 2017.","DOI":"10.1155\/2017\/6297651"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1172\/JCI134165","article-title":"Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease","volume":"2","author":"Smith","year":"2020","journal-title":"J. Clin. Investig."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jhep.2020.10.030","article-title":"Hepatokines and adipokines in NASH-related hepatocellular carcinoma","volume":"74","author":"Kucukoglu","year":"2021","journal-title":"J. Hepatol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1365-2265.2012.04433.x","article-title":"Relationships between sarcopenic obesity and insulin resistance, inflammation, and vitamin D status: The Korean Sarcopenic Obesity Study","volume":"78","author":"Kim","year":"2013","journal-title":"Clin. Endocrinol."},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Cespiati, A., Meroni, M., Lombardi, R., Oberti, G., Dongiovanni, P., and Fracanzani, A.L. (2022). Impact of Sarcopenia and Myosteatosis in Non-Cirrhotic Stages of Liver Diseases: Similarities and Differences across Aetiologies and Possible Therapeutic Strategies. Biomedicines, 10.","DOI":"10.3390\/biomedicines10010182"},{"key":"ref_122","first-page":"963","article-title":"Myosteatosis in the Context of Skeletal Muscle Function Deficit: An Interdisciplinary Workshop at the National Institute on Aging","volume":"7","author":"Addison","year":"2020","journal-title":"Front. Physiol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/jcsm.12039","article-title":"Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis","volume":"7","author":"Angulo","year":"2016","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_124","first-page":"388","article-title":"Myosteatosis, but not Sarcopenia, Predisposes NAFLD Subjects to Early Steatohepatitis and Fibrosis Progression","volume":"21","author":"Hsieh","year":"2023","journal-title":"Hepatology"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/jcsm.12646","article-title":"Myosteatosis rather than sarcopenia associates with non-alcoholic steatohepatitis in non-alcoholic fatty liver disease preclinical models","volume":"12","author":"Nachit","year":"2021","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/MCO.0b013e32834dd297","article-title":"Chronic low-grade inflammation and age-related sarcopenia","volume":"15","author":"Beyer","year":"2012","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000318741","article-title":"Obesity affects the liver\u2014the link between adipocytes and hepatocytes","volume":"83","author":"Wree","year":"2011","journal-title":"Digestion."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1111\/jcmm.14839","article-title":"PNPLA3 I148M mediates the regulatory effect of NF-kB on inflammation in PA-treated HepG2 cells","volume":"24","author":"Yuan","year":"2020","journal-title":"J. Cell Mol. Med."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"e22241","DOI":"10.1097\/MD.0000000000022241","article-title":"Quercetin inhibits TNF-\u03b1 induced HUVECs apoptosis and inflammation via downregulating NF-kB and AP-1 signaling pathway in vitro","volume":"99","author":"Chen","year":"2020","journal-title":"Medicine"},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Jimenez-Gutierrez, G.E., Mart\u00ednez-G\u00f3mez, L.E., Mart\u00ednez-Armenta, C., Pineda, C., Mart\u00ednez-Nava, G.A., and Lopez-Reyes, A. (2022). Molecular Mechanisms of Inflammation in Sarcopenia: Diagnosis and Therapeutic Update. Cells, 11.","DOI":"10.3390\/cells11152359"},{"key":"ref_131","first-page":"8859719","article-title":"Nonalcoholic Fatty Liver Disease and Sarcopenia: Where Do We Stand?","volume":"2020","author":"Mikolasevic","year":"2020","journal-title":"Gastroenterol. Hepatol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"5766","DOI":"10.1210\/jc.2003-030604","article-title":"Longitudinal Aging Study Amsterdam. Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): The Longitudinal Aging Study Amsterdam","volume":"88","author":"Visser","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1177\/1941738112461621","article-title":"Sports health benefits of vitamin d","volume":"4","author":"Shuler","year":"2012","journal-title":"Sports Health"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1152\/physrev.00014.2015","article-title":"Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects","volume":"96","author":"Christakos","year":"2016","journal-title":"Physiol. Rev."},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Remelli, F., Vitali, A., Zurlo, A., and Volpato, S. (2019). Vitamin D Deficiency and Sarcopenia in Older Persons. Nutrients, 11.","DOI":"10.3390\/nu11122861"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"19883","DOI":"10.1038\/s41598-021-99158-3","article-title":"Effect and mechanism of vitamin D activation disorder on liver fibrosis in biliary atresia","volume":"11","author":"Sun","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/apt.12377","article-title":"Meta-analysis: Vitamin D and non-alcoholic fatty liver disease","volume":"38","author":"Eliades","year":"2013","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/MEG.0000000000001486","article-title":"Association of serum vitamin D level and nonalcoholic fatty liver disease: A meta-analysis","volume":"32","author":"Liu","year":"2020","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Pop, T.L., S\u00eerbe, C., Ben\u0163a, G., Mititelu, A., and Grama, A. (2022). The Role of Vitamin D and Vitamin D Binding Protein in Chronic Liver Diseases. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms231810705"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/liv.12106","article-title":"Vitamin D in chronic liver disease","volume":"33","author":"Stokes","year":"2013","journal-title":"Liver Int."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1024\/0300-9831\/a000443","article-title":"Strong association between serum Vitamin D and Vaspin Levels, AIP, VAI and liver enzymes in NAFLD patients","volume":"90","author":"Izadi","year":"2020","journal-title":"Int. J. Vitam. Nutr. Res."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1051870","DOI":"10.3389\/fnut.2022.1051870","article-title":"Serum vitamin D status and circulating irisin levels in older adults with sarcopenia","volume":"7","author":"Wang","year":"2022","journal-title":"Front. Nutr."},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Barchetta, I., Del Ben, M., Angelico, F., Di Martino, M., Fraioli, A., La Torre, G., Saulle, R., Perri, L., Morini, S., and Tiberti, C. (2016). No effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial. BMC Med., 29.","DOI":"10.1186\/s12916-016-0638-y"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.3945\/jn.117.254292","article-title":"Patients with Nonalcoholic Fatty Liver Disease Have a Low Response Rate to Vitamin D Supplementation","volume":"147","author":"Dasarathy","year":"2017","journal-title":"J. Nutr."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"175","DOI":"10.15403\/jgld.2014.1121.252.cap","article-title":"Effect of Short-Term Vitamin D Correction on Hepatic Steatosis as Quantified by Controlled Attenuation Parameter (CAP)","volume":"25","author":"Papapostoli","year":"2016","journal-title":"J. Gastrointestin Liver Dis."},{"key":"ref_146","first-page":"7607","article-title":"A randomized placebo-controlled, double-blind study to investigate the effect of a high oral loading dose of cholecalciferol in non-alcoholic fatty liver disease patients, new insights on serum STAT-3 and hepassocin","volume":"27","author":"Alarfaj","year":"2023","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"835","DOI":"10.2147\/CIA.S132940","article-title":"Relationship between sarcopenia and physical activity in older people: A systematic review and meta-analysis","volume":"12","author":"Steffl","year":"2017","journal-title":"Clin. Interv. Aging"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s00198-009-1059-y","article-title":"Sarcopenia: Etiology, clinical consequences, intervention, and assessment","volume":"21","author":"Lang","year":"2010","journal-title":"Osteoporos. Int."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.clnu.2014.03.007","article-title":"Muscle contractile and metabolic dysfunction is a common feature of sarcopenia of aging and chronic diseases: From sarcopenic obesity to cachexia","volume":"33","author":"Biolo","year":"2014","journal-title":"Clin. Nutr."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/obr.12776","article-title":"Sarcopenia in patients with non-alcoholic fatty liver disease: Is it a clinically significant entity?","volume":"20","author":"Kwanten","year":"2019","journal-title":"Obes. Rev."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1620\/tjem.252.23","article-title":"Hybrid Training System Improves Insulin Resistance in Patients with Nonalcoholic Fatty Liver Disease: A Randomized Controlled Pilot Study","volume":"252","author":"Iwanaga","year":"2020","journal-title":"Tohoku J. Exp. Med."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1210\/endrev\/bnaa016","article-title":"Muscle-Organ Crosstalk: The Emerging Roles of Myokines","volume":"1","author":"Severinsen","year":"2020","journal-title":"Endocr. Rev."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1152\/physrev.90100.2007","article-title":"Muscle as an endocrine organ: Focus on muscle-derived interleukin-6","volume":"88","author":"Pedersen","year":"2008","journal-title":"Physiol. Rev."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s12072-019-09996-7","article-title":"Sarcopenia and fatty liver disease","volume":"13","author":"Kim","year":"2019","journal-title":"Hepatol. Int."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nrendo.2013.64","article-title":"The GH\/IGF-1 axis in obesity: Pathophysiology and therapeutic considerations","volume":"9","author":"Berryman","year":"2013","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/jcsm.12065","article-title":"Accelerometer-determined physical activity, muscle mass, and leg strength in community-dwelling older adults","volume":"7","author":"Foong","year":"2016","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.exger.2014.04.006","article-title":"The association between physical activity and reduced body fat lessens with age\u2014results from a cross-sectional study in community-dwelling older adults","volume":"55","author":"Foong","year":"2014","journal-title":"Exp. Gerontol."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1002\/cphy.c120033","article-title":"Muscle as a secretory organ","volume":"3","author":"Pedersen","year":"2013","journal-title":"Compr. Physiol."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"18162","DOI":"10.1073\/pnas.1317049110","article-title":"Hyperammonemia in cirrhosis induces transcriptional regulation of myostatin by an NF-\u03baB-mediated mechanism","volume":"5","author":"Qiu","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/jcsm.12833","article-title":"Metformin induces muscle atrophy by transcriptional regulation of myostatin via HDAC6 and FoxO3a","volume":"13","author":"Kang","year":"2022","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1096\/fj.201600675r","article-title":"New function of the myostatin\/activin type I receptor (ALK4) as a mediator of muscle atrophy and muscle regeneration","volume":"31","author":"Overzier","year":"2017","journal-title":"FASEB J."},{"key":"ref_162","first-page":"439","article-title":"Molecular Mechanisms of Obesity-Induced Osteoporosis and Muscle Atrophy","volume":"29","author":"Roy","year":"2016","journal-title":"Front. Physiol."},{"key":"ref_163","doi-asserted-by":"crossref","unstructured":"Kim, Y. (2021). Emerging Treatment Options for Sarcopenia in Chronic Liver Disease. Life, 11.","DOI":"10.3390\/life11030250"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/jcsm.12212","article-title":"Elevated serum myostatin level is associated with worse survival in patients with liver cirrhosis","volume":"8","author":"Nishikawa","year":"2017","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"716533","DOI":"10.3389\/fendo.2021.716533","article-title":"The Impact of Dysmetabolic Sarcopenia Among Insulin Sensitive Tissues: A Narrative Review","volume":"10","author":"Armandi","year":"2021","journal-title":"Front. Endocrinol."},{"key":"ref_166","doi-asserted-by":"crossref","unstructured":"Chen, C.-L., and Lin, Y.-C. (2022). Autophagy Dysregulation in Metabolic Associated Fatty Liver Disease: A New Therapeutic Target. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms231710055"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"16093","DOI":"10.1038\/s41598-020-73176-z","article-title":"Association between serum irisin concentrations and sarcopenia in patients with liver cirrhosis: A cross-sectional study","volume":"30","author":"Zhao","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_168","doi-asserted-by":"crossref","unstructured":"Kosmalski, M., Drzewoski, J., Szymczak-Pajor, I., Zieleniak, A., Miko\u0142ajczyk-Soli\u0144ska, M., Kasznicki, J., and \u015aliwi\u0144ska, A. (2022). Irisin Is Related to Non-Alcoholic Fatty Liver Disease (NAFLD). Biomedicines, 10.","DOI":"10.3390\/biomedicines10092253"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"175476","DOI":"10.1016\/j.ejphar.2022.175476","article-title":"Irisin ameliorates D-galactose-induced skeletal muscle fibrosis via the PI3K\/Akt pathway","volume":"939","author":"Wu","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"ref_170","doi-asserted-by":"crossref","unstructured":"Zhu, W., Sahar, N.E., Javaid, H.M.A., Pak, E.S., Liang, G., Wang, Y., Ha, H., and Huh, J.Y. (2021). Exercise-Induced Irisin Decreases Inflammation and Improves NAFLD by Competitive Binding with MD2. Cells, 10.","DOI":"10.3390\/cells10123306"},{"key":"ref_171","doi-asserted-by":"crossref","unstructured":"Choi, H.M., Doss, H.M., and Kim, K.S. (2020). Multifaceted Physiological Roles of Adiponectin in Inflammation and Diseases. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21041219"},{"key":"ref_172","doi-asserted-by":"crossref","unstructured":"Shih, P.-H., Shiue, S.-J., Chen, C.-N., Cheng, S.-W., Lin, H.-Y., Wu, L.-W., and Wu, M.-S. (2021). Fucoidan and Fucoxanthin Attenuate Hepatic Steatosis and Inflammation of NAFLD through Modulation of Leptin\/Adiponectin Axis. Mar. Drugs, 19.","DOI":"10.3390\/md19030148"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1172\/JCI29709","article-title":"Adiponectin modulates inflammatory reactions via calreticulin receptor-dependent clearance of early apoptotic bodies","volume":"117","author":"Takemura","year":"2007","journal-title":"J. Clin. Investig."},{"key":"ref_174","doi-asserted-by":"crossref","unstructured":"Shabalala, S.C., Dludla, S.C., Mabasa, L., Kappo, A.P., Basson, A.K., Pheiffer, C., and Johnson, R. (2020). The effect of adiponectin in the pathogenesis of non-alcoholic fatty liver disease (NAFLD) and the potential role of polyphenols in the modulation of adiponectin signaling. Biomed. Pharmacother., 131.","DOI":"10.1016\/j.biopha.2020.110785"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"546445","DOI":"10.3389\/fmed.2020.546445","article-title":"Adiponectin Inhibits NLRP3 Inflammasome Activation in Nonalcoholic Steatohepatitis via AMPK-JNK\/ErK1\/2-NF\u03baB\/ROS Signaling Pathways","volume":"7","author":"Dong","year":"2020","journal-title":"Front. Med."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1146\/annurev-immunol-051116-052415","article-title":"Immune Responses in the Liver","volume":"36","author":"Kubes","year":"2018","journal-title":"Annu. Rev. Immunol."},{"key":"ref_177","doi-asserted-by":"crossref","unstructured":"Milosevic, I., Vujovic, A., Barac, A., Djelic, M., Korac, M., Radovanovic Spurnic, A., Gmizic, I., Stevanovic, O., Djordjevic, V., and Lekic, N. (2019). Gut-Liver Axis, Gut Microbiota, and Its Modulation in the Management of Liver Diseases: A Review of the Literature. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20020395"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.jhep.2017.05.007","article-title":"Targeting the gut-liver axis in liver disease","volume":"67","author":"Wiest","year":"2017","journal-title":"J. Hepatol."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"e9302","DOI":"10.15252\/emmm.201809302","article-title":"The role of the microbiome in NAFLD and NASH","volume":"11","author":"Kolodziejczyk","year":"2019","journal-title":"EMBO Mol. Med."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"26800","DOI":"10.1038\/srep26800","article-title":"Impaired Gut-Liver-Brain Axis in Patients with Cirrhosis","volume":"6","author":"Ahluwalia","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_181","doi-asserted-by":"crossref","unstructured":"Nishikawa, H., Enomoto, H., Nishiguchi, S., and Iijima, H. (2021). Sarcopenic Obesity in Liver Cirrhosis: Possible Mechanism and Clinical Impact. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22041917"},{"key":"ref_182","doi-asserted-by":"crossref","unstructured":"Gojda, J., and Cahova, M. (2021). Gut Microbiota as the Link between Elevated BCAA Serum Levels and Insulin Resistance. Biomolecules, 11.","DOI":"10.3390\/biom11101414"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s12576-019-00670-z","article-title":"Effects of chronic Porphyromonas gingivalis lipopolysaccharide infusion on skeletal muscles in mice","volume":"69","author":"Kawamura","year":"2019","journal-title":"J. Physiol. Sci."},{"key":"ref_184","doi-asserted-by":"crossref","unstructured":"Xue, L., Deng, Z., Luo, W., He, X., and Chen, Y. (2022). Effect of Fecal Microbiota Transplantation on Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial. Front. Cell. Infect. Microbiol., 12.","DOI":"10.3389\/fcimb.2022.759306"},{"key":"ref_185","doi-asserted-by":"crossref","unstructured":"Calabrese, F.M., Disciglio, V., Franco, I., Sorino, P., Bonfiglio, C., Bianco, A., Campanella, A., Lippolis, T., Pesole, P.L., and Polignano, M. (2022). A Low Glycemic Index Mediterranean Diet Combined with Aerobic Physical Activity Rearranges the Gut Microbiota Signature in NAFLD Patients. Nutrients, 14.","DOI":"10.3390\/nu14091773"}],"container-title":["Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-1729\/14\/1\/37\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:41:47Z","timestamp":1760132507000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-1729\/14\/1\/37"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,25]]},"references-count":185,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["life14010037"],"URL":"https:\/\/doi.org\/10.3390\/life14010037","relation":{},"ISSN":["2075-1729"],"issn-type":[{"value":"2075-1729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,25]]}}}